top of page
Abstract resized.webp

Abstract Submission Deadline: 31 JULY 2024 (Extended)

You are invited to submit informative abstracts of up to 500 words (2800 characters) which would not include the title of the abstract, author affiliations and other headings like Aims, Methods, Results & Conclusions. The abstract may include a maximum of two charts or figures as Supporting Data (which will not be included in 500 words / 2800 characters limit).

Abstracts must be submitted according to guidelines given below. All abstracts must be submitted using the Abstract Submission Form. 


Please write the title in Title Case (each main word has a capital letter). Do not use quotation marks.

e.g. The Results of the Research Case Study and Its Participants


  • The full names (no initials) of all participating authors (including yourself) must be included on the abstract. Please do not include degrees or professional titles.

  • Author Affiliations – please include the name of your organization, the city, the state and the country.

Element 3.png


Abstracts that merely state the results that will be presented will be subject to rejection. All abstracts are subject to review by the Scientific Committee and acceptance into the program is not guaranteed. The Committee suggests that the abstract follow the format outlined below:

  • Aims

  • Methods

  • Results

  • Conclusions


If the research described in the abstract was supported by a commercial company, you must indicate the company’s role in analysing the data or preparing the abstract.

One of the following must appear at the bottom of the abstract:

“No conflict of interest to disclose”.

“This research was supported by                  . The company had no role in analysing the data or preparing the abstract.”

“This research was supported by                  . The company inserts free text describing company role in data analysis or abstract preparation.”

This conflict-of-interest statement is mandatory for all abstracts submitted and will appear wherever the abstracts are published. For oral presentations, a sample slide will be available to presenters for disclosure of conflicts of interest to be displayed as the first or second slide of their presentation 


The abstracts must be submitted in one of the following categories:

  • Acute Leukemia

  • Lymphoma and Chronic Lymphocytic Leukemia

  • Multiple Myeloma

  • Myelodysplastic Syndromes

  • Myeloproliferative Neoplasm

  • Hemoglobinopathies, Primary Immune Deficiency, and Metabolic Disorders

  • Conditioning Regimens

  • Graft-versus-host Disease

  • Infectious and Non-infectious complications

  • Pediatric Transplantation

  • Cell and Gene Therapy

  • Quality of Life / Survivorship

  • Basic Science

  • Allied Health including Nursing, Pharmacology, and Laboratory Aspects

Submission of the abstract carries with it an obligation to present the accepted abstract in person or virtually without any change in scientific content during the allotted time in the above conference. Withdrawal of presentation should be intimated to the scientific committee on or before 31 AUGUST 2024, by writing to the conference Secretariat at

If an author as the presenting author is not able to present the paper for the conference due to any reason, prior permission has to be obtained from the Program Committee regarding the change in the presenting author.


  • Poster size & material: A0 (Portrait)​ Foamboard 5mm 

  • Participants are kindly advised to bring their own posters, which will be displayed at the event.

  • The poster must contain the name of all authors and the author’s Institution or University


Presenting Author's Particulars



Mailing Address*

Postal Code*

Contact Number* 

Full Name*


City & State / Province*



Abstract Information

Preferred Mode of Presentation*

(Subject to the Scientific Committee's decision)

Abstract category*

Type of Abstract*

Abstract Title*

Please write the title in Title Case (each main word has a capital letter). Do not use quotation marks.

e.g. The Results of the Research Case Study and Its Participants

Abstract Content*

Text length NOT to exceed 500 words. The text of the abstract should include section headings such as Aims, Methods, Results and Conclusions.  The section headings should appear in bold.

Word Count: 0

Upload Supporting Data in PDF

Co-author(s)' Information

There is no co-author for this abstract.

Full Name*



Institution of Affiliation*

City & State / Province*


There is no co-author for this abstract.

Element 3.png

Thank you for your submission!

An acknowledgement email with your assigned Abstract ID will be sent to your email.

The committee will review all abstract submissions and inform you if your abstract is accepted.

More details​ are coming soon!

Element 3.png

Powered by

AveLIVE logo new.png
bottom of page